CCAN 0.750   +0.032 +4.50% Updated: 04-18-2017 $CCAN

New Post Public Reply Private Reply Replies (0) Message Board
stockcharts
79
CCAN 0.750   +0.032 +4.50% Updated: 04-18-2017 $CCAN
Last Trade: 4/18/2017 3:44:00 PM
Last 0.750   +0.032 +4.50%
Open 0.750
Previous Close 0.718
Day High / Low 0.780 / 0.740
Year High / Low 30.000 / 0.400
Volume 88,383
Projected Volume 88383 (109%)
# of Trades / Projected 76 / 76
Dividend / Yield - / -
Abnormal Activity NONE
Abnormal Volume NO
Gap NONE
Candle NEUTRAL
Volatility Today MEDIUM
Volatility Yesterday HIGH
Price Relativity
From 40 Day High 100%
From 80 Day High 100%
From 150 Day High 69%
From 40 Day Low 234%
From 80 Day Low 234%
From 150 Day Low 234%
Pivot Analysis
Price Pivot $ 0.760
Day Resistance 1 $ 0.770
Day Support 1 $ 0.730
Day Resistance 2 $ 0.800
Day Support 2 $ 0.720
Consolidations
Short Term YES
Medium Term NO
Long Term NO
Volume Indicators
20 Day Avg Vol 81,442
Today / 20 Day Avg Vol ABOVE
150 Day Avg Vol 66,443
Today / 150 Day Avg Vol ABOVE
Abnormal Volume NO
William Volume Accumulation bullish
Volume Price Trend bullish
Momentum Indicators
10 Day Trend bullish
40 Day Trend bearish
100 Day Trend bearish
Stochastics neutral
RSI neutral
MACD bullish
Moving Average Indictors
15 Day Trend bullish
45 Day Trend bullish
100 Day Trend bullish
Mid Term Moving Average Crossover NONE
Long Term Moving Average Crossover NONE
Volatility Indicators
Abnormal Activity Today? NONE
Volatility Index Today MEDIUM
Volatility Index Yesterday HIGH
10 Day Volatility DECREASING
20 Day Volatility INCREASING
40 Day Volatility INCREASING

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Stellar Elevates Leadership with Key Promotions to Drive Growth

Updated Category News Views 212

Stellar Strengthens Leadership Team for Future Success The new Executive Vice Presidents, Senior Vice President, and Vice Presidents will assume leadership roles this month. Stellar, an integrated design-build firm, proudly announces a strategic expansion of its leadership team, marking an important milestone in the company's ongoing growth and development. CEO Brian...

Continue Reading
Revolutionizing Fashion: Pixelz's Digital Twins Transform AI

Updated Category News Views 197

Transforming Fashion Content Creation Pixelz, a pioneering platform in fashion e-commerce content creation, has made headlines with its innovative approach to Artificial Intelligence (AI) featuring Digital Twins. This groundbreaking solution empowers brands to produce stunning, campaign-quality imagery rapidly and with creativity, thanks to a unique collaboration with...

Continue Reading
Alstom's First Half Results for Fiscal Year 2024/25 Unveiled

Updated Category News Views 212

Alstom's First Half Results Overview Alstom, a leading player in the transportation sector, recently shared significant updates regarding its performance in the first half of the fiscal year 2024/25. The presentation showcases their commitment to growth, innovation, and sustainability throughout the railway industry. Financial Highlights During this presentation, Alstom...

Continue Reading
Brooke Shields Leads 'Hearts of Heroes' Season 8

Updated Category News Views 10

A New Face Shines on 'Hearts of Heroes' Buckle up, folks! Brooke Shields is strapping in for the eighth season of 'Hearts of Heroes,' the award-winning show spotlighting everyday champions and first responders. Premiering on July 11, this series lands a spot in ABC's Weekend Adventure block, thrusting Shields into the limelight as she takes the baton from previous hosts...

Continue Reading
Cytokinetics' MYQORZO® Gains Approval for Hypertrophic Cardiomyopathy

Updated Category News Views 118

Cytokinetics' MYQORZO® Achieves NMPA Approval in China Cytokinetics, Incorporated (NASDAQ: CYTK) has exciting news—the approval of MYQORZO® (aficamten) by the China National Medical Products Administration (NMPA) for adults suffering from obstructive hypertrophic cardiomyopathy (oHCM). This milestone not only underscores the effectiveness of their innovative therapy...

Continue Reading